Cooper Companies, Inc. (The) (COO) Stock Rating Reaffirmed by BMO Capital Markets

BMO Capital Markets reiterated their buy rating on shares of Cooper Companies, Inc. (The) (NYSE:COO) in a report released on Friday, September 1st. They currently have a $272.00 price objective on the medical device company’s stock.

Several other brokerages have also recently issued reports on COO. Zacks Investment Research raised Cooper Companies, Inc. (The) from a hold rating to a buy rating and set a $277.00 target price on the stock in a research report on Tuesday, August 29th. Robert W. Baird reiterated a buy rating and set a $251.00 price objective on shares of Cooper Companies, Inc. (The) in a report on Thursday, August 24th. J P Morgan Chase & Co reiterated a neutral rating and set a $206.00 price objective (up previously from $200.00) on shares of Cooper Companies, Inc. (The) in a report on Monday, June 5th. Jefferies Group LLC set a $250.00 price objective on Cooper Companies, Inc. (The) and gave the company a buy rating in a report on Thursday, August 17th. Finally, Cleveland Research reiterated a buy rating on shares of Cooper Companies, Inc. (The) in a report on Tuesday, August 22nd. Six equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Cooper Companies, Inc. (The) has a consensus rating of Buy and an average price target of $257.60.

Shares of Cooper Companies, Inc. (COO) traded down 0.74% on Friday, reaching $245.21. The company’s stock had a trading volume of 862,709 shares. The firm has a 50-day moving average price of $245.23 and a 200 day moving average price of $224.59. Cooper Companies, Inc. has a one year low of $158.73 and a one year high of $256.39. The firm has a market capitalization of $11.98 billion, a PE ratio of 36.76 and a beta of 0.59.

Cooper Companies, Inc. (The) (NYSE:COO) last announced its earnings results on Thursday, August 31st. The medical device company reported $2.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.58 by $0.06. The business had revenue of $556.00 million for the quarter, compared to analysts’ expectations of $552.32 million. Cooper Companies, Inc. (The) had a return on equity of 16.00% and a net margin of 16.45%. The business’s revenue for the quarter was up 8.0% on a year-over-year basis. During the same quarter last year, the firm earned $2.30 EPS. On average, analysts anticipate that Cooper Companies, Inc. will post $9.72 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This news story was published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this news story on another website, it was illegally stolen and republished in violation of US & international copyright laws. The legal version of this news story can be accessed at https://ledgergazette.com/2017/09/17/cooper-companies-inc-the-coo-earns-buy-rating-from-bmo-capital-markets.html.

In other Cooper Companies, Inc. (The) news, Director Gary S. Petersmeyer sold 3,977 shares of Cooper Companies, Inc. (The) stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Randal Golden sold 1,621 shares of Cooper Companies, Inc. (The) stock in a transaction dated Tuesday, July 11th. The shares were sold at an average price of $243.65, for a total value of $394,956.65. Following the transaction, the vice president now owns 1,731 shares of the company’s stock, valued at approximately $421,758.15. The disclosure for this sale can be found here. Insiders sold a total of 20,992 shares of company stock valued at $5,167,628 in the last 90 days. 1.60% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Lord Abbett & CO. LLC raised its stake in shares of Cooper Companies, Inc. (The) by 2.1% during the 2nd quarter. Lord Abbett & CO. LLC now owns 405,831 shares of the medical device company’s stock valued at $97,164,000 after buying an additional 8,316 shares during the last quarter. Sentry Investment Management LLC raised its stake in shares of Cooper Companies, Inc. (The) by 0.7% during the 2nd quarter. Sentry Investment Management LLC now owns 2,801 shares of the medical device company’s stock valued at $671,000 after buying an additional 19 shares during the last quarter. Toronto Dominion Bank raised its stake in shares of Cooper Companies, Inc. (The) by 25.3% during the 2nd quarter. Toronto Dominion Bank now owns 16,552 shares of the medical device company’s stock valued at $3,963,000 after buying an additional 3,344 shares during the last quarter. Advisory Services Network LLC raised its stake in shares of Cooper Companies, Inc. (The) by 30.6% during the 2nd quarter. Advisory Services Network LLC now owns 457 shares of the medical device company’s stock valued at $109,000 after buying an additional 107 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in shares of Cooper Companies, Inc. (The) during the 2nd quarter valued at about $423,000. Institutional investors and hedge funds own 95.92% of the company’s stock.

Cooper Companies, Inc. (The) Company Profile

The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.

Analyst Recommendations for Cooper Companies, Inc. (The) (NYSE:COO)

Receive News & Ratings for Cooper Companies Inc. (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc. (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply